← Back to headlines
AbbVie's Venetoclax Achieves Milestone in CLL Treatment
AbbVie Inc. (ABBV) has reached a new milestone with its drug Venetoclax in the treatment of Chronic Lymphocytic Leukemia (CLL), marking significant progress in oncology.
1 Jul, 19:53 — 1 Jul, 19:53
Sources
Showing 1 of 1 sources
